Home > Healthcare > Medical Devices > Therapeutic Devices > Proton Therapy Systems Market
Proton Therapy Systems Market was valued at USD 1.2 billion in 2022 and is estimated to account for USD 3.2 billion by 2032.
Cancer is a major health concern worldwide, and its prevalence is increasing at an alarming rate. The World Cancer Research Fund International estimated that approximately 19 million new cancer cases were registered in 2021, and this number is anticipated to increase to 24 million by 2035, globally. Moreover, according to the American Cancer Society, around 1.9 million new cases of cancer were diagnosed in the U.S. alone in 2021. Thus, rise in the number of cancer cases is one of the major drivers of growth in the market.
The growing demand for non-invasive cancer treatment options is driving the growth of the proton therapy systems market. Proton therapy is a non-invasive treatment option that delivers high doses of radiation to cancer cells while minimizing damage to surrounding healthy tissues. This makes it a striking option for patients that want to avoid the side effects associated with traditional cancer treatments such as chemotherapy and surgery. Various other advantages associated with proton therapy systems, such as high precision and radiation control, reduced risk of side effects, and minimal exposure of normal tissues to radiation, make it the most suitable treatment option for pediatric cancer cases especially. Thus, these factors are considered as major factors leading the market industry.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Proton Therapy Systems Market Size in 2022: | USD 1.2 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 10.8% |
2032 Value Projection: | USD 3.2 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 150 |
Tables, Charts & Figures: | 261 |
Segments covered: | Set-up Type, Indication, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|